# Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS

Study · id `cardio:ct-nct05027984` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05027984](<https://clinicaltrials.gov/study/NCT05027984>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05027984

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1425 participants.

## Technical summary

Registry record NCT05027984. Randomized; single masking; primary purpose treatment. Start 2021-06-30 (actual); primary completion 2027-01-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1425 participants (enrolled count; ClinicalTrials.gov record NCT05027984, source copy `cardio:ctgov-nct05027984-2026-10-22`, retrieved 2026-10-26)
- Started: 2021-06-30 (actual) (ClinicalTrials.gov record NCT05027984, source copy `cardio:ctgov-nct05027984-2026-10-22`, retrieved 2026-10-26)
- Primary completion: 2027-01-31 (anticipated) (ClinicalTrials.gov record NCT05027984, source copy `cardio:ctgov-nct05027984-2026-10-22`, retrieved 2026-10-26)
- Completion: 2030-03-31 (anticipated) (ClinicalTrials.gov record NCT05027984, source copy `cardio:ctgov-nct05027984-2026-10-22`, retrieved 2026-10-26)
- Countries: Greece; Italy; Spain; Switzerland (ClinicalTrials.gov record NCT05027984, source copy `cardio:ctgov-nct05027984-2026-10-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05027984-2026-10-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS
- Acronym: INTERCLIMA
- Condition: Coronary Artery Disease
- Condition: Coronary Disease
- Condition: Ischemic Heart Disease
- Intervention (Device): Optical coherence tomography
- Intervention (Device): iFR/FFR/RFR
- Lead sponsor: Centro per la Lotta Contro l'Infarto - Fondazione Onlus
- Lead sponsor class: OTHER
- Collaborator: Abbott Medical Devices
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as a collaborator: Abbott (`cardio:abbott`)

## Provenance

Content hash: e2d713b03afe493f13052f59cf5361aaa1436ebc996e1ad8bf309704e0ddadef
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
